Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients